Cargando…

The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease

The N6-methyladenosine (m6A) modification is the most abundant internal modification of messenger RNA (mRNA) in higher eukaryotes. Under the actions of methyltransferase, demethylase and methyl-binding protein, m6A resulting from RNA methylation becomes dynamic and reversible, similar to that from D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Teng, Atteh, Lawrence Lawer, Zhang, Xianzhuo, Huang, Chongfei, Bai, Mingzhen, Ma, Haidong, Zhang, Chao, Fu, Wenkang, Gao, Long, Lin, Yanyan, Meng, Wenbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Surgery
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8831730/ https://www.ncbi.nlm.nih.gov/pubmed/35155557 http://dx.doi.org/10.3389/fsurg.2022.819335

Ejemplares similares

Phosphoproteomics reveals that cinobufotalin promotes intrahepatic cholangiocarcinoma cell apoptosis by activating the ATM/CHK2/p53 signaling pathway
por: Xia, Zhili, et al.
Publicado: (2022)

Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota
por: Tian, Liang, et al.
Publicado: (2023)

The role of extracellular vesicles in cholangiocarcinoma
por: Bai, Mingzhen, et al.
Publicado: (2020)

The Interaction Between N(6)-Methyladenosine Modification and Non-Coding RNAs in Gastrointestinal Tract Cancers
por: Yao, Lin, et al.
Publicado: (2022)

The evaluation of different types fecal bacteria products for the treatment of recurrent Clostridium difficile associated diarrhea: A systematic review and network meta-analysis
por: Yang, Liping, et al.
Publicado: (2022)

Methyladenosine Modification in RNAs: Classification and Roles in Gastrointestinal Cancers
por: Li, Qinghai, et al.
Publicado: (2021)

N(6)-methyladenosine (m(6)A) RNA modification in gastrointestinal tract cancers: roles, mechanisms, and applications
por: Hu, Bin-bin, et al.
Publicado: (2019)

N(6)-Methyladenosine mRNA Modification: From Modification Site Selectivity to Neurological Functions
por: Zhang, Zeyu, et al.
Publicado: (2023)

Saline irrigation for reducing the recurrence of common bile duct stones after lithotripsy: a randomized controlled trial
por: Lin, Yanyan, et al.
Publicado: (2023)

A meta-analysis of based radiomics for predicting lymph node metastasis in patients with biliary tract cancers
por: Ma, Yuhu, et al.
Publicado: (2023)

Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients
por: Zheng, Xinyu, et al.
Publicado: (2023)

Identification of hub genes involved in the occurrence and development of hepatocellular carcinoma via bioinformatics analysis
por: Mi, Ningning, et al.
Publicado: (2020)

Editorial: Neuroendocrine tumors of the gastrointestinal tract, liver, and pancreas: current management and treatment strategies
por: Giakoustidis, Alexandros, et al.
Publicado: (2023)

Risk factor analysis and construction of prediction models for short-term postoperative complications in patients undergoing gastrointestinal tract surgery
por: Cui, Hongming, et al.
Publicado: (2023)

N6-methyladenosine modification governs liver glycogenesis by stabilizing the glycogen synthase 2 mRNA
por: Zhang, Xiang, et al.
Publicado: (2022)

N6-methyladenosine mRNA methylation is important for the light response in soybean
por: Zhang, Liya, et al.
Publicado: (2023)

Reversible RNA Modification N(1)-methyladenosine (m(1)A) in mRNA and tRNA
por: Zhang, Chi, et al.
Publicado: (2018)

Role of N6-methyladenosine RNA modification in gastric cancer
por: Ding, Si-Qi, et al.
Publicado: (2023)

Clinical implantation of 92 VACStents in the upper gastrointestinal tract of 50 patients—applicability and safety analysis of an innovative endoscopic concept
por: Lange, J., et al.
Publicado: (2023)

Function of N6-Methyladenosine Modification in Tumors
por: Zhang, Nan, et al.
Publicado: (2021)

Emerging roles of N6-methyladenosine (m(6)A) modification in breast cancer
por: Wang, Yanyan, et al.
Publicado: (2020)

N(6)-methyladenosine modification of ITGA6 mRNA promotes the development and progression of bladder cancer
por: Jin, Huan, et al.
Publicado: (2019)

Editorial: Endoscopic vacuum therapy (EVT) in the gastrointestinal tract—a paradigm shift in the surgical treatment and prevention of anastomotic insufficiencies and perforations
por: Heiss, Markus M., et al.
Publicado: (2023)

Regulatory Role of N6-methyladenosine (m(6)A) Modification in Osteosarcoma
por: Zhang, Yujie, et al.
Publicado: (2021)

METTL3-mediated N(6)-methyladenosine mRNA modification enhances long-term memory consolidation
por: Zhang, Zeyu, et al.
Publicado: (2018)

Epigenetic regulation of N6‐methyladenosine modifications in obesity
por: Sun, Mingli, et al.
Publicado: (2021)

Midline incisional hernia prophylaxis using synthetic mesh in an emergency or urgent gastrointestinal tract surgery: a protocol for multicentre randomised clinical trial
por: Tansawet, Amarit, et al.
Publicado: (2021)

Preoperative prognostic nutritional index predicts short-term complications after radical resection of distal cholangiocarcinoma
por: He, Yulong, et al.
Publicado: (2023)

The functions of N6-methyladenosine modification in lncRNAs
por: He, Rong-Zhang, et al.
Publicado: (2020)

Corrigendum to “Function of N6-Methyladenosine Modification in Tumors”
por: Zhang, Nan, et al.
Publicado: (2023)

Fistulization of Peritoneal Hydatid Cyst to the Gastrointestinal Tract: An Unusual Cause of Subacute Intestinal Obstruction
por: Sharma, Sarthak, et al.
Publicado: (2019)

The importance of N6-methyladenosine modification in tumor immunity and immunotherapy
por: Zhang, Ze, et al.
Publicado: (2022)

CSTF2 mediated mRNA N(6)-methyladenosine modification drives pancreatic ductal adenocarcinoma m(6)A subtypes
por: Zheng, Yanfen, et al.
Publicado: (2023)

The Role of N(6)-Methyladenosine Modification in Microvascular Dysfunction
por: Zhang, Ye-Ran, et al.
Publicado: (2022)

METTL3 regulates N6-methyladenosine modification of ANGPTL3 mRNA and potentiates malignant progression of stomach adenocarcinoma
por: Zhang, Zhijin, et al.
Publicado: (2023)

N(1)-Methyladenosine modification of mRNA regulates neuronal gene expression and oxygen glucose deprivation/reoxygenation induction
por: Qi, Zhangyang, et al.
Publicado: (2023)

Roles and implications of mRNA N(6) ‐methyladenosine in cancer
por: Zeng, Lingxing, et al.
Publicado: (2023)

WTAP-mediated N(6)-methyladenosine modification of NLRP3 mRNA in kidney injury of diabetic nephropathy
por: Lan, Jianzi, et al.
Publicado: (2022)

N(6)-methyladenosine-modified lncRNA and mRNA modification profiles in cerebral ischemia-reperfusion injury
por: Shao, Le, et al.
Publicado: (2022)

N6‐methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export
por: Xu, Penghui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k1ceubje60ba1mpl2gf26buiog